APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisinopril

Compare research editions
View pricing & licenses

Selected research

Industry Research

Lisinopril Industry Research Report 2026

19 December 2025143 pages

Choose your research edition.

Industry ResearchLisinopril Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisinopril Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Lisinopril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisinopril Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisinopril Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Lisinopril market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Lisinopril is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Lisinopril is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Lisinopril is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Lisinopril include Teva Pharmaceuticals, Novartis, Mylan Pharmaceuticals, Astrazeneca, Wockhardt, West Ward Pharmaceutical, Watson Laboratories, Vintage Pharmaceuticals and SUN Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Lisinopril market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lisinopril Market by Company

Teva Pharmaceuticals

Novartis

Mylan Pharmaceuticals

Astrazeneca

Wockhardt

West Ward Pharmaceutical

Watson Laboratories

Vintage Pharmaceuticals

SUN Pharm

Ranbaxy Pharmaceuticals

Prinston

Merck Research Laboratories

Lupin

Lek Pharmaceuticals

Ivax Pharmaceuticals

Invagen Pharms

Hikma

CASI Pharms

Aurobindo Pharma

Apotex

Alvogen

Actavis Elizabeth

Accord Hlthcare

Lisinopril Segment by Type

10mg

2.5mg

20mg

30mg

40mg

5mg

Lisinopril Segment by Application

Hospital

Drug Store

Lisinopril Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisinopril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisinopril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisinopril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Lisinopril manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Lisinopril by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Lisinopril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lisinopril Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Lisinopril Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Lisinopril Sales Market Share by Manufacturers (2021-2026) Table 8. Global Lisinopril Revenue of Manufacturers (2021-2026) Table 9. Global Lisinopril Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Lisinopril Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Lisinopril Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Lisinopril, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Lisinopril, Product Type & Application Table 14. Global Lisinopril Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Lisinopril by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceuticals Company Information Table 19. Teva Pharmaceuticals Business Overview Table 20. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Pharmaceuticals Lisinopril Product Portfolio Table 22. Teva Pharmaceuticals Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Novartis Lisinopril Product Portfolio Table 27. Novartis Recent Developments Table 28. Mylan Pharmaceuticals Company Information Table 29. Mylan Pharmaceuticals Business Overview Table 30. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Mylan Pharmaceuticals Lisinopril Product Portfolio Table 32. Mylan Pharmaceuticals Recent Developments Table 33. Astrazeneca Company Information Table 34. Astrazeneca Business Overview Table 35. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Astrazeneca Lisinopril Product Portfolio Table 37. Astrazeneca Recent Developments Table 38. Wockhardt Company Information Table 39. Wockhardt Business Overview Table 40. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Wockhardt Lisinopril Product Portfolio Table 42. Wockhardt Recent Developments Table 43. West Ward Pharmaceutical Company Information Table 44. West Ward Pharmaceutical Business Overview Table 45. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. West Ward Pharmaceutical Lisinopril Product Portfolio Table 47. West Ward Pharmaceutical Recent Developments Table 48. Watson Laboratories Company Information Table 49. Watson Laboratories Business Overview Table 50. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Watson Laboratories Lisinopril Product Portfolio Table 52. Watson Laboratories Recent Developments Table 53. Vintage Pharmaceuticals Company Information Table 54. Vintage Pharmaceuticals Business Overview Table 55. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Vintage Pharmaceuticals Lisinopril Product Portfolio Table 57. Vintage Pharmaceuticals Recent Developments Table 58. SUN Pharm Company Information Table 59. SUN Pharm Business Overview Table 60. SUN Pharm Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. SUN Pharm Lisinopril Product Portfolio Table 62. SUN Pharm Recent Developments Table 63. Ranbaxy Pharmaceuticals Company Information Table 64. Ranbaxy Pharmaceuticals Business Overview Table 65. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Ranbaxy Pharmaceuticals Lisinopril Product Portfolio Table 67. Ranbaxy Pharmaceuticals Recent Developments Table 68. Prinston Company Information Table 69. Prinston Business Overview Table 70. Prinston Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Prinston Lisinopril Product Portfolio Table 72. Prinston Recent Developments Table 73. Merck Research Laboratories Company Information Table 74. Merck Research Laboratories Business Overview Table 75. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck Research Laboratories Lisinopril Product Portfolio Table 77. Merck Research Laboratories Recent Developments Table 78. Lupin Company Information Table 79. Lupin Business Overview Table 80. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Lupin Lisinopril Product Portfolio Table 82. Lupin Recent Developments Table 83. Lek Pharmaceuticals Company Information Table 84. Lek Pharmaceuticals Business Overview Table 85. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Lek Pharmaceuticals Lisinopril Product Portfolio Table 87. Lek Pharmaceuticals Recent Developments Table 88. Ivax Pharmaceuticals Company Information Table 89. Ivax Pharmaceuticals Business Overview Table 90. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ivax Pharmaceuticals Lisinopril Product Portfolio Table 92. Ivax Pharmaceuticals Recent Developments Table 93. Invagen Pharms Company Information Table 94. Invagen Pharms Business Overview Table 95. Invagen Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Invagen Pharms Lisinopril Product Portfolio Table 97. Invagen Pharms Recent Developments Table 98. Hikma Company Information Table 99. Hikma Business Overview Table 100. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hikma Lisinopril Product Portfolio Table 102. Hikma Recent Developments Table 103. CASI Pharms Company Information Table 104. CASI Pharms Business Overview Table 105. CASI Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CASI Pharms Lisinopril Product Portfolio Table 107. CASI Pharms Recent Developments Table 108. Aurobindo Pharma Company Information Table 109. Aurobindo Pharma Business Overview Table 110. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Aurobindo Pharma Lisinopril Product Portfolio Table 112. Aurobindo Pharma Recent Developments Table 113. Apotex Company Information Table 114. Apotex Business Overview Table 115. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Apotex Lisinopril Product Portfolio Table 117. Apotex Recent Developments Table 118. Alvogen Company Information Table 119. Alvogen Business Overview Table 120. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Alvogen Lisinopril Product Portfolio Table 122. Alvogen Recent Developments Table 123. Actavis Elizabeth Company Information Table 124. Actavis Elizabeth Business Overview Table 125. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Actavis Elizabeth Lisinopril Product Portfolio Table 127. Actavis Elizabeth Recent Developments Table 128. Accord Hlthcare Company Information Table 129. Accord Hlthcare Business Overview Table 130. Accord Hlthcare Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Accord Hlthcare Lisinopril Product Portfolio Table 132. Accord Hlthcare Recent Developments Table 133. Global Lisinopril Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Lisinopril Sales by Region (2021-2026) & (K Units) Table 135. Global Lisinopril Sales Market Share by Region (2021-2026) Table 136. Global Lisinopril Sales by Region (2027-2032) & (K Units) Table 137. Global Lisinopril Sales Market Share by Region (2027-2032) Table 138. Global Lisinopril Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Lisinopril Revenue Market Share by Region (2021-2026) Table 140. Global Lisinopril Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Lisinopril Revenue Market Share by Region (2027-2032) Table 142. North America Lisinopril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Lisinopril Sales by Country (2021-2026) & (K Units) Table 144. North America Lisinopril Sales by Country (2027-2032) & (K Units) Table 145. North America Lisinopril Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Lisinopril Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Lisinopril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Lisinopril Sales by Country (2021-2026) & (K Units) Table 149. Europe Lisinopril Sales by Country (2027-2032) & (K Units) Table 150. Europe Lisinopril Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Lisinopril Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Lisinopril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Lisinopril Sales by Country (2021-2026) & (K Units) Table 154. Asia Pacific Lisinopril Sales by Country (2027-2032) & (K Units) Table 155. Asia Pacific Lisinopril Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Lisinopril Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Lisinopril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Lisinopril Sales by Country (2021-2026) & (K Units) Table 159. South America Lisinopril Sales by Country (2027-2032) & (K Units) Table 160. South America Lisinopril Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Lisinopril Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Lisinopril Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Lisinopril Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Lisinopril Sales by Country (2027-2032) & (K Units) Table 165. Middle East and Africa Lisinopril Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Lisinopril Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Lisinopril Sales by Type (2021-2026) & (K Units) Table 168. Global Lisinopril Sales by Type (2027-2032) & (K Units) Table 169. Global Lisinopril Sales Market Share by Type (2021-2026) Table 170. Global Lisinopril Sales Market Share by Type (2027-2032) Table 171. Global Lisinopril Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Lisinopril Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Lisinopril Revenue Market Share by Type (2021-2026) Table 174. Global Lisinopril Revenue Market Share by Type (2027-2032) Table 175. Global Lisinopril Price by Type (2021-2026) & (US$/Unit) Table 176. Global Lisinopril Price by Type (2027-2032) & (US$/Unit) Table 177. Global Lisinopril Sales by Application (2021-2026) & (K Units) Table 178. Global Lisinopril Sales by Application (2027-2032) & (K Units) Table 179. Global Lisinopril Sales Market Share by Application (2021-2026) Table 180. Global Lisinopril Sales Market Share by Application (2027-2032) Table 181. Global Lisinopril Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Lisinopril Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Lisinopril Revenue Market Share by Application (2021-2026) Table 184. Global Lisinopril Revenue Market Share by Application (2027-2032) Table 185. Global Lisinopril Price by Application (2021-2026) & (US$/Unit) Table 186. Global Lisinopril Price by Application (2027-2032) & (US$/Unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Lisinopril Distributors List Table 190. Lisinopril Customers List Table 191. Lisinopril Industry Trends Table 192. Lisinopril Industry Drivers Table 193. Lisinopril Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lisinopril Product Image Figure 5. Global Lisinopril Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Lisinopril Market Size (2021-2032) & (US$ Million) Figure 7. Global Lisinopril Sales (2021-2032) & (K Units) Figure 8. Global Lisinopril Average Price (US$/Unit) & (2021-2032) Figure 9. 10mg Product Image Figure 10. 2.5mg Product Image Figure 11. 20mg Product Image Figure 12. 30mg Product Image Figure 13. 40mg Product Image Figure 14. 5mg Product Image Figure 15. Hospital Product Image Figure 16. Drug Store Product Image Figure 17. Global Lisinopril Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Lisinopril, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Lisinopril Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Lisinopril Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Lisinopril Sales by Region in 2025 Figure 23. Global Lisinopril Revenue by Region in 2025 Figure 24. North America Lisinopril Market Size by Country in 2025 Figure 25. North America Lisinopril Sales Market Share by Country (2021-2032) Figure 26. North America Lisinopril Revenue Market Share by Country (2021-2032) Figure 27. United States Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Lisinopril Market Size by Country in 2025 Figure 30. Europe Lisinopril Sales Market Share by Country (2021-2032) Figure 31. Europe Lisinopril Revenue Market Share by Country (2021-2032) Figure 32. Germany Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Lisinopril Market Size by Country in 2025 Figure 38. Asia Pacific Lisinopril Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Lisinopril Revenue Market Share by Country (2021-2032) Figure 40. China Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Lisinopril Market Size by Country in 2025 Figure 49. South America Lisinopril Sales Market Share by Country (2021-2032) Figure 50. South America Lisinopril Revenue Market Share by Country (2021-2032) Figure 51. Mexico Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Lisinopril Market Size by Country in 2025 Figure 55. Middle East and Africa Lisinopril Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Lisinopril Revenue Market Share by Country (2021-2032) Figure 57. Turkey Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Lisinopril Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Lisinopril Sales Market Share by Type (2021-2032) Figure 61. Global Lisinopril Revenue Market Share by Type (2021-2032) Figure 62. Global Lisinopril Price (US$/Unit) by Type (2021-2032) Figure 63. Global Lisinopril Sales Market Share by Application (2021-2032) Figure 64. Global Lisinopril Revenue Market Share by Application (2021-2032) Figure 65. Global Lisinopril Price (US$/Unit) by Application (2021-2032) Figure 66. Lisinopril Value Chain Figure 67. Lisinopril Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Lisinopril Industry Opportunities and Challenges

Scope & coverage.

Types
  • 10mg
  • 2.5mg
  • 20mg
  • 30mg
  • 40mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva Pharmaceuticals
  • Novartis
  • Mylan Pharmaceuticals
  • Astrazeneca
  • Wockhardt
  • West Ward Pharmaceutical
  • Watson Laboratories
  • Vintage Pharmaceuticals
  • SUN Pharm
  • Ranbaxy Pharmaceuticals
  • Prinston
  • Merck Research Laboratories
  • Lupin
  • Lek Pharmaceuticals
  • Ivax Pharmaceuticals
  • Invagen Pharms
  • Hikma
  • CASI Pharms
  • Aurobindo Pharma
  • Apotex
  • Alvogen
  • Actavis Elizabeth
  • Accord Hlthcare

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Lisinopril Market Size (2021-2032)
  4. 2.2.2 Global Lisinopril Sales (2021-2032)
  5. 2.2.3 Global Lisinopril Market Average Price (2021-2032)
  6. 2.3 Lisinopril by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 10mg
  9. 2.3.3 2.5mg
  10. 2.3.4 20mg
  11. 2.3.5 30mg
  12. 2.3.6 40mg
  13. 2.3.7 5mg
  14. 2.4 Lisinopril by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Hospital
  17. 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Lisinopril Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Lisinopril Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Lisinopril Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Lisinopril Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Lisinopril Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Lisinopril, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Lisinopril, Product Type & Application
  8. 3.8 Global Manufacturers of Lisinopril, Established Date
  9. 3.9 Global Lisinopril Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceuticals
  2. 4.1.1 Teva Pharmaceuticals Company Information
  3. 4.1.2 Teva Pharmaceuticals Business Overview
  4. 4.1.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceuticals Lisinopril Product Portfolio
  6. 4.1.5 Teva Pharmaceuticals Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Lisinopril Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Mylan Pharmaceuticals
  14. 4.3.1 Mylan Pharmaceuticals Company Information
  15. 4.3.2 Mylan Pharmaceuticals Business Overview
  16. 4.3.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Mylan Pharmaceuticals Lisinopril Product Portfolio
  18. 4.3.5 Mylan Pharmaceuticals Recent Developments
  19. 4.4 Astrazeneca
  20. 4.4.1 Astrazeneca Company Information
  21. 4.4.2 Astrazeneca Business Overview
  22. 4.4.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Astrazeneca Lisinopril Product Portfolio
  24. 4.4.5 Astrazeneca Recent Developments
  25. 4.5 Wockhardt
  26. 4.5.1 Wockhardt Company Information
  27. 4.5.2 Wockhardt Business Overview
  28. 4.5.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Wockhardt Lisinopril Product Portfolio
  30. 4.5.5 Wockhardt Recent Developments
  31. 4.6 West Ward Pharmaceutical
  32. 4.6.1 West Ward Pharmaceutical Company Information
  33. 4.6.2 West Ward Pharmaceutical Business Overview
  34. 4.6.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 West Ward Pharmaceutical Lisinopril Product Portfolio
  36. 4.6.5 West Ward Pharmaceutical Recent Developments
  37. 4.7 Watson Laboratories
  38. 4.7.1 Watson Laboratories Company Information
  39. 4.7.2 Watson Laboratories Business Overview
  40. 4.7.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Watson Laboratories Lisinopril Product Portfolio
  42. 4.7.5 Watson Laboratories Recent Developments
  43. 4.8 Vintage Pharmaceuticals
  44. 4.8.1 Vintage Pharmaceuticals Company Information
  45. 4.8.2 Vintage Pharmaceuticals Business Overview
  46. 4.8.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Vintage Pharmaceuticals Lisinopril Product Portfolio
  48. 4.8.5 Vintage Pharmaceuticals Recent Developments
  49. 4.9 SUN Pharm
  50. 4.9.1 SUN Pharm Company Information
  51. 4.9.2 SUN Pharm Business Overview
  52. 4.9.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 SUN Pharm Lisinopril Product Portfolio
  54. 4.9.5 SUN Pharm Recent Developments
  55. 4.10 Ranbaxy Pharmaceuticals
  56. 4.10.1 Ranbaxy Pharmaceuticals Company Information
  57. 4.10.2 Ranbaxy Pharmaceuticals Business Overview
  58. 4.10.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Ranbaxy Pharmaceuticals Lisinopril Product Portfolio
  60. 4.10.5 Ranbaxy Pharmaceuticals Recent Developments
  61. 4.11 Prinston
  62. 4.11.1 Prinston Company Information
  63. 4.11.2 Prinston Business Overview
  64. 4.11.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Prinston Lisinopril Product Portfolio
  66. 4.11.5 Prinston Recent Developments
  67. 4.12 Merck Research Laboratories
  68. 4.12.1 Merck Research Laboratories Company Information
  69. 4.12.2 Merck Research Laboratories Business Overview
  70. 4.12.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Merck Research Laboratories Lisinopril Product Portfolio
  72. 4.12.5 Merck Research Laboratories Recent Developments
  73. 4.13 Lupin
  74. 4.13.1 Lupin Company Information
  75. 4.13.2 Lupin Business Overview
  76. 4.13.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Lupin Lisinopril Product Portfolio
  78. 4.13.5 Lupin Recent Developments
  79. 4.14 Lek Pharmaceuticals
  80. 4.14.1 Lek Pharmaceuticals Company Information
  81. 4.14.2 Lek Pharmaceuticals Business Overview
  82. 4.14.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Lek Pharmaceuticals Lisinopril Product Portfolio
  84. 4.14.5 Lek Pharmaceuticals Recent Developments
  85. 4.15 Ivax Pharmaceuticals
  86. 4.15.1 Ivax Pharmaceuticals Company Information
  87. 4.15.2 Ivax Pharmaceuticals Business Overview
  88. 4.15.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Ivax Pharmaceuticals Lisinopril Product Portfolio
  90. 4.15.5 Ivax Pharmaceuticals Recent Developments
  91. 4.16 Invagen Pharms
  92. 4.16.1 Invagen Pharms Company Information
  93. 4.16.2 Invagen Pharms Business Overview
  94. 4.16.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Invagen Pharms Lisinopril Product Portfolio
  96. 4.16.5 Invagen Pharms Recent Developments
  97. 4.17 Hikma
  98. 4.17.1 Hikma Company Information
  99. 4.17.2 Hikma Business Overview
  100. 4.17.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hikma Lisinopril Product Portfolio
  102. 4.17.5 Hikma Recent Developments
  103. 4.18 CASI Pharms
  104. 4.18.1 CASI Pharms Company Information
  105. 4.18.2 CASI Pharms Business Overview
  106. 4.18.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 CASI Pharms Lisinopril Product Portfolio
  108. 4.18.5 CASI Pharms Recent Developments
  109. 4.19 Aurobindo Pharma
  110. 4.19.1 Aurobindo Pharma Company Information
  111. 4.19.2 Aurobindo Pharma Business Overview
  112. 4.19.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Aurobindo Pharma Lisinopril Product Portfolio
  114. 4.19.5 Aurobindo Pharma Recent Developments
  115. 4.20 Apotex
  116. 4.20.1 Apotex Company Information
  117. 4.20.2 Apotex Business Overview
  118. 4.20.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Apotex Lisinopril Product Portfolio
  120. 4.20.5 Apotex Recent Developments
  121. 4.21 Alvogen
  122. 4.21.1 Alvogen Company Information
  123. 4.21.2 Alvogen Business Overview
  124. 4.21.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Alvogen Lisinopril Product Portfolio
  126. 4.21.5 Alvogen Recent Developments
  127. 4.22 Actavis Elizabeth
  128. 4.22.1 Actavis Elizabeth Company Information
  129. 4.22.2 Actavis Elizabeth Business Overview
  130. 4.22.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Actavis Elizabeth Lisinopril Product Portfolio
  132. 4.22.5 Actavis Elizabeth Recent Developments
  133. 4.23 Accord Hlthcare
  134. 4.23.1 Accord Hlthcare Company Information
  135. 4.23.2 Accord Hlthcare Business Overview
  136. 4.23.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Accord Hlthcare Lisinopril Product Portfolio
  138. 4.23.5 Accord Hlthcare Recent Developments
5 Global Lisinopril Market Scenario by Region
  1. 5.1 Global Lisinopril Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Lisinopril Sales by Region: 2021-2032
  3. 5.2.1 Global Lisinopril Sales by Region: 2021-2026
  4. 5.2.2 Global Lisinopril Sales by Region: 2027-2032
  5. 5.3 Global Lisinopril Revenue by Region: 2021-2032
  6. 5.3.1 Global Lisinopril Revenue by Region: 2021-2026
  7. 5.3.2 Global Lisinopril Revenue by Region: 2027-2032
  8. 5.4 North America Lisinopril Market Facts & Figures by Country
  9. 5.4.1 North America Lisinopril Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Lisinopril Sales by Country (2021-2032)
  11. 5.4.3 North America Lisinopril Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Lisinopril Market Facts & Figures by Country
  15. 5.5.1 Europe Lisinopril Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Lisinopril Sales by Country (2021-2032)
  17. 5.5.3 Europe Lisinopril Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Lisinopril Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Lisinopril Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Lisinopril Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Lisinopril Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Lisinopril Market Facts & Figures by Country
  35. 5.7.1 South America Lisinopril Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Lisinopril Sales by Country (2021-2032)
  37. 5.7.3 South America Lisinopril Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Lisinopril Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Lisinopril Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Lisinopril Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Lisinopril Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Lisinopril Sales by Type (2021-2032)
  2. 6.1.1 Global Lisinopril Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Lisinopril Sales Market Share by Type (2021-2032)
  4. 6.2 Global Lisinopril Revenue by Type (2021-2032)
  5. 6.2.1 Global Lisinopril Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Lisinopril Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Lisinopril Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Lisinopril Sales by Application (2021-2032)
  2. 7.1.1 Global Lisinopril Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Lisinopril Sales Market Share by Application (2021-2032)
  4. 7.2 Global Lisinopril Revenue by Application (2021-2032)
  5. 7.2.1 Global Lisinopril Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Lisinopril Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Lisinopril Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Lisinopril Value Chain Analysis
  2. 8.1.1 Lisinopril Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Lisinopril Production Mode & Process
  5. 8.2 Lisinopril Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Lisinopril Distributors
  8. 8.2.3 Lisinopril Customers
9 Global Lisinopril Analyzing Market Dynamics
  1. 9.1 Lisinopril Industry Trends
  2. 9.2 Lisinopril Industry Drivers
  3. 9.3 Lisinopril Industry Opportunities and Challenges
  4. 9.4 Lisinopril Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst